Navigation Links
Indevus and FDA Agree on Path Forward for NEBIDO(R)
Date:9/26/2008

Existing European Data Will Be Used for NDA Resubmission

Planned For First Quarter 2009

LEXINGTON, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) with regard to the additional data and risk management strategy that will lead to re-submission (complete response) of the New Drug Application (NDA) for NEBIDO(R) in the first quarter of calendar 2009. The re-submission database will include experience from over 14,000 injections in more than 2,600 patients, all of which come from existing clinical trials conducted in the U.S. and post-marketing studies that have been conducted in Europe. FDA stated that the number of patients and the number of injections of testosterone undecanoate from these studies appear to provide an adequate size database to determine the precise incidence of serious post-injection, oil-based reactions.

Indevus and FDA also agreed on an education plan to minimize the risks associated with the clinical use of testosterone undecanoate intramuscular injection, namely, to reduce the incidence and/or severity of the serious oil- based reactions. Further, Indevus and FDA agreed to obtain skin-testing data to characterize an allergic component to the drug or any of its excipients in certain patients. Indevus has also agreed to conduct a large, simple post- marketing study of the safety of NEBIDO in approximately 10,000 patients.

"We are very pleased that we can provide to FDA additional data from existing clinical trials to satisfy FDA's desire to understand the incidence of these rare oil-based reactions, without the need to conduct new clinica
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Indevus Announces Private Placement of $105 Million of Non-Recourse Notes
2. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
3. Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2008 Financial Results on August 5, 2008
4. Indevus Receives Approvable Letter from FDA for NEBIDO(R)
5. Indevus Announces Management Changes
6. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
7. 125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative
8. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
9. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
10. Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
11. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... San Francisco, California (PRWEB) July 31, 2014 ... expert systems that inform therapeutic decision-making in oncology, today ... on August 14, 2014 to discuss the Company's financial ... to provide an update about the business in the ... live audio call beginning on Thursday, August 14, 2014, ...
(Date:7/31/2014)... China , July 31, 2014 ... Irys™System by BGI , the world,s ... comprehensive exploration of human structural variation (SV) and to ... including those where no reference exists. In addition, BioNano ... for multiplexing on the Irys System, enabling significantly higher ...
(Date:7/31/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:7/31/2014)... Wash. , July 31, 2014   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media and precision thermal shipping products for ... second quarter 2014 financial results will be released on ... host a conference call and live webcast at 4:30 ...
Breaking Biology Technology:CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2
... to tight integration and ... excellent value, ... a,leader in radiology and medical image and information management solutions,today announced ... 100 facilities that use MEDITECH(TM) as their health,information system. AMICAS will ...
... May 27 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), ... announced that the,Ministry of Health has purchased approximately ... hepatitis A vaccine, Healive(R), to,vaccinate people living in ... has delivered shipments of the Healive vaccine to,Sichuan, ...
... Calif., May 27 Epitomics, Inc., the rabbit,monoclonal ... its,1000th new rabbit monoclonal antibody. Each antibody has ... proprietary rabbit monoclonal,antibody technology. "We are very excited ... of time. This demonstrated the robustness of our ...
Cached Biology Technology:AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 3Sinovac Receives RMB 20 Million Purchase Order for Healive from China's Ministry of Health to Vaccinate Earthquake Victims 2Epitomics Announces the Creation of 1000th Rabbit Monoclonal Antibody 2
(Date:7/31/2014)... people make a rational choice to be liberal or ... it a matter of genetics?, Two political scientists from ... University say that neither conscious decision-making nor parental upbringing ... lean right. , A growing body of evidence shows ... core of political differences, the researchers say in the ...
(Date:7/31/2014)... known as the Rim Fire was in full fury, ... when it entered the backcountry of Yosemite National Park ... inside the park, the battle began to turn, enacting ... drought can combine to fuel large, severe fires. , ... encountered lands where fire had been used as a ...
(Date:7/31/2014)... 31, 2014 Biometrics industry sees ... smart technologies; companies turn towards digital currency: NXT-ID, Inc. ... Amazon.com Inc. (NASDAQ: AMZN ), Facebook Inc. ... GOOG ) and Microsoft Corporation (NASDAQ: MSFT) ... the growing m-commerce market, announces a video featuring its ...
Breaking Biology News(10 mins):Scientists find growing consensus: Political attitudes derive from body and mind 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6
... Argonne National Laboratory has signed a memorandum ... (SRNL) to collaborate on nuclear energy and environmental ... Energy Department (DOE) needs and other important national ... a leader in nuclear energy research," Argonne director ...
... Maneuvering through a room full of people. Jumping out of ... these seemingly simple actions require us to perceive and quickly ... Rensselaer Polytechnic Institute Mark Changizi argues they require something moreour ... nearly one-tenth of a second to translate the light that ...
... has detected the molecule hydroxyl on another planet for ... new tool to unlock the workings of Venuss dense ... made up of a hydrogen and oxygen atom each. ... the Venusian atmosphere, some 100 km above the surface, ...
Cached Biology News:Argonne-SRNL agreement supports critical DOE, national priorities 2Crystal (eye) ball: Study says visual system equipped with 'future seeing powers' 2Crystal (eye) ball: Study says visual system equipped with 'future seeing powers' 3Key molecule discovered in Venus's atmosphere 2
... is the universal bioinformatics software that has ... The unique modular design of BioNumerics allows ... any type of data employed for the ... DNA fingerprints, 2-D protein gels, HPLC, VNTR, ...
Request Info...
Cultrex 3D Culture Matrix Rat Collagen I....
Cultrex 3D Culture Matrix BME....
Biology Products: